| Year |
Citation |
Score |
| 2020 |
Choi SJ, Ma TC, Ding Y, Cheung T, Joshi N, Sulzer D, Mosharov EV, Kang UJ. Alterations in the intrinsic properties of striatal cholinergic interneurons after dopamine lesion and chronic L-DOPA. Elife. 9. PMID 32687053 DOI: 10.7554/Elife.56920 |
0.373 |
|
| 2020 |
Papa SM, Brundin P, Fung VSC, Kang UJ, Burn DJ, Colosimo C, Chiang HL, Alcalay RN, Trenkwalder C. Impact of the COVID-19 Pandemic on Parkinson's Disease and Movement Disorders. Movement Disorders Clinical Practice. 7: 357-360. PMID 32373651 DOI: 10.1002/Mdc3.12953 |
0.332 |
|
| 2020 |
Papa SM, Brundin P, Fung VSC, Kang UJ, Burn DJ, Colosimo C, Chiang HL, Alcalay RN, Trenkwalde C. Impact of the COVID-19 pandemic on Parkinson's disease and movement disorders. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 32250460 DOI: 10.1002/Mds.28067 |
0.332 |
|
| 2020 |
Choi SJ, Ma TC, Ding Y, Cheung T, Joshi N, Sulzer D, Mosharov EV, Kang UJ. Author response: Alterations in the intrinsic properties of striatal cholinergic interneurons after dopamine lesion and chronic L-DOPA Elife. DOI: 10.7554/Elife.56920.Sa2 |
0.344 |
|
| 2019 |
Hu Y, Zhang K, Zhang T, Wang J, Chen F, Qin W, Tong W, Guan Q, He Y, Gu C, Chen X, Kang UJ, Sun YE, Li S, Jin L. Exercise Reverses Dysregulation of T-Cell-Related Function in Blood Leukocytes of Patients With Parkinson's Disease. Frontiers in Neurology. 10: 1389. PMID 32047471 DOI: 10.3389/Fneur.2019.01389 |
0.33 |
|
| 2019 |
Luo L, Andrews H, Alcalay RN, Poyraz FC, Boehme AK, Goldman JG, Xie T, Tuite P, Henchcliffe C, Hogarth P, Amara AW, Frank S, Sutherland M, Kopil C, Naito A, ... Kang UJ, et al. Motor phenotype classification in moderate to advanced PD in BioFIND study. Parkinsonism & Related Disorders. PMID 31255537 DOI: 10.1016/J.Parkreldis.2019.06.017 |
0.332 |
|
| 2019 |
Kang UJ, Boehme AK, Fairfoul G, Shahnawaz M, Ma TC, Hutten SJ, Green A, Soto C. Comparative study of cerebrospinal fluid α-synuclein seeding aggregation assays for diagnosis of Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 30840785 DOI: 10.1002/Mds.27646 |
0.323 |
|
| 2019 |
Alcalay RN, Mallett V, Vanderperre B, Tavassoly O, Dauvilliers Y, Wu RYJ, Ruskey JA, Leblond CS, Ambalavanan A, Laurent SB, Spiegelman D, Dionne-Laporte A, Liong C, Levy OA, Fahn S, ... ... Kang UJ, et al. SMPD1 mutations, activity, and α-synuclein accumulation in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 30788890 DOI: 10.1002/Mds.27642 |
0.361 |
|
| 2018 |
Meszaros J, Cheung T, Erler MM, Kang UJ, Sames D, Kellendonk C, Sulzer D. Evoked transients of pH-sensitive fluorescent false neurotransmitter reveal dopamine hot spots in the globus pallidus. Elife. 7. PMID 30566076 DOI: 10.7554/Elife.42383 |
0.608 |
|
| 2018 |
Chuhma N, Mingote S, Yetnikoff L, Kalmbach A, Ma T, Ztaou S, Sienna AC, Tepler S, Poulin JF, Ansorge M, Awatramani R, Kang UJ, Rayport S. Dopamine neuron glutamate cotransmission evokes a delayed excitation in lateral dorsal striatal cholinergic interneurons. Elife. 7. PMID 30295607 DOI: 10.7554/Elife.39786 |
0.359 |
|
| 2018 |
Li H, Ham A, Ma TC, Kuo SH, Kanter E, Kim D, Ko HS, Quan Y, Sardi SP, Li A, Arancio O, Kang UJ, Sulzer D, Tang G. Mitochondrial Dysfunction and Mitophagy Defect Triggered by Heterozygous GBA Mutations. Autophagy. PMID 30160596 DOI: 10.1080/15548627.2018.1509818 |
0.301 |
|
| 2018 |
Xie T, Bloom L, Padmanaban M, Bertacchi B, Kang W, MacCracken E, Dachman A, Vigil J, Satzer D, Zadikoff C, Markopoulou K, Warnke P, Kang UJ. Long-term effect of low frequency stimulation of STN on dysphagia, freezing of gait and other motor symptoms in PD. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 29654112 DOI: 10.1136/Jnnp-2018-318060 |
0.348 |
|
| 2018 |
Sulzer D, Cassidy C, Horga G, Kang UJ, Fahn S, Casella L, Pezzoli G, Langley J, Hu XP, Zucca FA, Isaias IU, Zecca L. Neuromelanin detection by magnetic resonance imaging (MRI) and its promise as a biomarker for Parkinson's disease. Npj Parkinson's Disease. 4: 11. PMID 29644335 DOI: 10.1038/S41531-018-0047-3 |
0.388 |
|
| 2018 |
Kim R, Lee J, Kim Y, Kim A, Jang M, Kim HJ, Jeon B, Kang UJ, Fahn S. Presynaptic striatal dopaminergic depletion predicts the later development of freezing of gait in de novo Parkinson's disease: An analysis of the PPMI cohort. Parkinsonism & Related Disorders. PMID 29523394 DOI: 10.1016/J.Parkreldis.2018.02.047 |
0.426 |
|
| 2018 |
Alcalay RN, Wolf P, Levy OA, Kang UJ, Waters C, Fahn S, Ford B, Kuo SH, Vanegas N, Shah H, Liong C, Narayan S, Pauciulo MW, Nichols WC, Gan-Or Z, et al. Alpha galactosidase A activity in Parkinson's disease. Neurobiology of Disease. PMID 29369793 DOI: 10.1016/J.Nbd.2018.01.012 |
0.333 |
|
| 2018 |
Meszaros J, Cheung T, Erler MM, Kang UJ, Sames D, Kellendonk C, Sulzer D. Author response: Evoked transients of pH-sensitive fluorescent false neurotransmitter reveal dopamine hot spots in the globus pallidus Elife. DOI: 10.7554/Elife.42383.020 |
0.59 |
|
| 2018 |
Chuhma N, Mingote S, Yetnikoff L, Kalmbach A, Ma T, Ztaou S, Sienna A, Tepler S, Poulin J, Ansorge M, Awatramani R, Kang UJ, Rayport S. Author response: Dopamine neuron glutamate cotransmission evokes a delayed excitation in lateral dorsal striatal cholinergic interneurons Elife. DOI: 10.7554/Elife.39786.027 |
0.354 |
|
| 2018 |
Cassidy C, Girgis R, Zecca L, Zucca F, Bellei C, Baker S, Weinstein J, Martinez CB, Kang U, Snellenberg JV, Sulzer D, Abi-Dargham A, Horga G. S236. Neuromelanin-Sensitive MRI: A Novel, Non-Invasive Proxy Measure of Dopamine Function in Neuropsychiatric Illness Biological Psychiatry. 83. DOI: 10.1016/J.Biopsych.2018.02.1128 |
0.32 |
|
| 2017 |
Martelli D, Luo L, Kang J, Kang UJ, Fahn S, Agrawal SK. Adaptation of Stability during Perturbed Walking in Parkinson's Disease. Scientific Reports. 7: 17875. PMID 29259237 DOI: 10.1038/S41598-017-18075-6 |
0.35 |
|
| 2017 |
Goldman JG, Andrews H, Amara A, Naito A, Alcalay RN, Shaw LM, Taylor P, Xie T, Tuite P, Henchcliffe C, Hogarth P, Frank S, Saint-Hilaire MH, Frasier M, Arnedo V, ... ... Kang UJ, et al. Cerebrospinal fluid, plasma, and saliva in the BioFIND study: Relationships among biomarkers and Parkinson's disease Features. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 29205509 DOI: 10.1002/Mds.27232 |
0.355 |
|
| 2017 |
Sklerov M, Kang UJ, Liong C, Clark L, Marder K, Pauciulo M, Nichols WC, Chung WK, Honig LS, Cortes E, Vonsattel JP, Alcalay RN. Frequency of GBA variants in autopsy-proven multiple system atrophy. Movement Disorders Clinical Practice. 4: 574-581. PMID 28966932 DOI: 10.1002/Mdc3.12481 |
0.302 |
|
| 2017 |
Chan RB, Perotte AJ, Zhou B, Liong C, Shorr EJ, Marder KS, Kang UJ, Waters CH, Levy OA, Xu Y, Shim HB, Pe'er I, Di Paolo G, Alcalay RN. Elevated GM3 plasma concentration in idiopathic Parkinson's disease: A lipidomic analysis. Plos One. 12: e0172348. PMID 28212433 DOI: 10.1371/Journal.Pone.0172348 |
0.336 |
|
| 2016 |
Xie T, Kang UJ. Comments on the recent viewpoint article on low-frequency deep brain stimulation for Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 27862290 DOI: 10.1002/Mds.26861 |
0.318 |
|
| 2016 |
Barca E, Kleiner G, Tang G, Ziosi M, Tadesse S, Masliah E, Louis ED, Faust P, Kang UJ, Torres J, Cortes EP, Vonsattel JG, Kuo SH, Quinzii CM. Decreased Coenzyme Q10 Levels in Multiple System Atrophy Cerebellum. Journal of Neuropathology and Experimental Neurology. PMID 27235405 DOI: 10.1093/Jnen/Nlw037 |
0.334 |
|
| 2016 |
Kang UJ, Goldman JG, Alcalay RN, Xie T, Tuite P, Henchcliffe C, Hogarth P, Amara AW, Frank S, Rudolph A, Casaceli C, Andrews H, Gwinn K, Sutherland M, Kopil C, et al. The BioFIND study: Characteristics of a clinically typical Parkinson's disease biomarker cohort. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 27113479 DOI: 10.1002/Mds.26613 |
0.365 |
|
| 2016 |
Alcalay RN, Levy OA, Wolf P, Oliva P, Zhang XK, Waters CH, Fahn S, Kang U, Liong C, Ford B, Mazzoni P, Kuo S, Johnson A, Xiong L, Rouleau GA, et al. SCARB2 variants and glucocerebrosidase activity in Parkinson's disease. Npj Parkinson's Disease. 2. PMID 27110593 DOI: 10.1038/Npjparkd.2016.4 |
0.307 |
|
| 2015 |
Jankovic J, Bressman S, Dauer W, Kang UJ. Clinical and scientific perspectives on movement disorders: Stanley Fahn's contributions. Movement Disorders : Official Journal of the Movement Disorder Society. 30: 1862-9. PMID 26477883 DOI: 10.1002/Mds.26445 |
0.304 |
|
| 2015 |
Bastide MF, Meissner WG, Picconi B, Fasano S, Fernagut PO, Feyder M, Francardo V, Alcacer C, Ding Y, Brambilla R, Fisone G, Jon Stoessl A, Bourdenx M, Engeln M, Navailles S, ... ... Kang UJ, et al. Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease. Progress in Neurobiology. PMID 26209473 DOI: 10.1016/J.Pneurobio.2015.07.002 |
0.354 |
|
| 2015 |
Cazorla M, Kang UJ, Kellendonk C. Balancing the basal ganglia circuitry: a possible new role for dopamine D2 receptors in health and disease. Movement Disorders : Official Journal of the Movement Disorder Society. 30: 895-903. PMID 26018615 DOI: 10.1002/Mds.26282 |
0.64 |
|
| 2015 |
Lim SA, Xia R, Ding Y, Won L, Ray WJ, Hitchcock SA, McGehee DS, Kang UJ. Enhanced histamine H2 excitation of striatal cholinergic interneurons in L-DOPA-induced dyskinesia. Neurobiology of Disease. 76: 67-76. PMID 25661301 DOI: 10.1016/J.Nbd.2015.01.003 |
0.379 |
|
| 2015 |
Stewart T, Sossi V, Aasly JO, Wszolek ZK, Uitti RJ, Hasegawa K, Yokoyama T, Zabetian CP, Leverenz JB, Stoessl AJ, Wang Y, Ginghina C, Liu C, Cain KC, Auinger P, ... Kang UJ, et al. Phosphorylated α-synuclein in Parkinson's disease: correlation depends on disease severity. Acta Neuropathologica Communications. 3: 7. PMID 25637461 DOI: 10.1186/S40478-015-0185-3 |
0.365 |
|
| 2015 |
Xie T, Vigil J, MacCracken E, Gasparaitis A, Young J, Kang W, Bernard J, Warnke P, Kang UJ. Low-frequency stimulation of STN-DBS reduces aspiration and freezing of gait in patients with PD. Neurology. 84: 415-20. PMID 25540305 DOI: 10.1212/Wnl.0000000000001184 |
0.342 |
|
| 2015 |
Cazorla M, Kang UJ, Kellendonk C. Balancing the basal ganglia circuitry: A possible new role for dopamine D2 receptors in health and disease Movement Disorders. 30: 895-903. DOI: 10.1002/mds.26282 |
0.579 |
|
| 2014 |
Lim SA, Kang UJ, McGehee DS. Striatal cholinergic interneuron regulation and circuit effects. Frontiers in Synaptic Neuroscience. 6: 22. PMID 25374536 DOI: 10.3389/Fnsyn.2014.00022 |
0.356 |
|
| 2014 |
Beal MF, Oakes D, Shoulson I, Henchcliffe C, Galpern WR, Haas R, Juncos JL, Nutt JG, Voss TS, Ravina B, Shults CM, Helles K, Snively V, Lew MF, ... ... Kang UJ, et al. A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit. Jama Neurology. 71: 543-52. PMID 24664227 DOI: 10.1001/Jamaneurol.2014.131 |
0.339 |
|
| 2014 |
Won L, Ding Y, Singh P, Kang UJ. Striatal cholinergic cell ablation attenuates L-DOPA induced dyskinesia in parkinsonian mice Journal of Neuroscience. 34: 3090-3094. PMID 24553948 DOI: 10.1523/Jneurosci.2888-13.2014 |
0.376 |
|
| 2014 |
Lin W, Wadlington NL, Chen L, Zhuang X, Brorson JR, Kang UJ. Loss of PINK1 attenuates HIF-1α induction by preventing 4E-BP1-dependent switch in protein translation under hypoxia. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 34: 3079-89. PMID 24553947 DOI: 10.1523/Jneurosci.2286-13.2014 |
0.348 |
|
| 2014 |
Frasier M, Kang UJ. Parkinson's disease biomarkers: Resources for discovery and validation Neuropsychopharmacology. 39: 241-242. PMID 24317317 DOI: 10.1038/Npp.2013.246 |
0.378 |
|
| 2013 |
Zhang J, Mattison HA, Liu C, Ginghina C, Auinger P, McDermott MP, Stewart T, Kang UJ, Cain KC, Shi M. Longitudinal assessment of tau and amyloid beta in cerebrospinal fluid of Parkinson disease. Acta Neuropathologica. 126: 671-82. PMID 23644819 DOI: 10.1007/S00401-013-1121-X |
0.345 |
|
| 2013 |
Zhuang X, Mazzoni P, Kang UJ. The role of neuroplasticity in dopaminergic therapy for Parkinson disease. Nature Reviews. Neurology. 9: 248-56. PMID 23588357 DOI: 10.1038/Nrneurol.2013.57 |
0.447 |
|
| 2012 |
Khoo SK, Petillo D, Kang UJ, Resau JH, Berryhill B, Linder J, Forsgren L, Neuman LA, Tan AC. Plasma-based circulating MicroRNA biomarkers for Parkinson's disease. Journal of Parkinson's Disease. 2: 321-31. PMID 23938262 DOI: 10.3233/Jpd-012144 |
0.368 |
|
| 2012 |
Kang UJ, Xie T. Diagnostic biomarkers of Parkinson's disease: what gain at what cost? Journal of Neurology, Neurosurgery, and Psychiatry. 83: 769. PMID 22733084 DOI: 10.1136/Jnnp-2012-302529 |
0.343 |
|
| 2012 |
Xie T, Kang UJ, Warnke P. Effect of stimulation frequency on immediate freezing of gait in newly activated STN DBS in Parkinson's disease. Journal of Neurology, Neurosurgery, and Psychiatry. 83: 1015-7. PMID 22696586 DOI: 10.1136/Jnnp-2011-302091 |
0.311 |
|
| 2012 |
Kang UJ, Auinger P. Activity enhances dopaminergic long-duration response in Parkinson disease Neurology. 78: 1146-1149. PMID 22459675 DOI: 10.1212/Wnl.0B013E31824F8056 |
0.405 |
|
| 2011 |
Shim JH, Yoon SH, Kim KH, Han JY, Ha JY, Hyun DH, Paek SH, Kang UJ, Zhuang X, Son JH. The antioxidant Trolox helps recovery from the familial Parkinson's disease-specific mitochondrial deficits caused by PINK1- and DJ-1-deficiency in dopaminergic neuronal cells. Mitochondrion. 11: 707-15. PMID 21664494 DOI: 10.1016/J.Mito.2011.05.013 |
0.404 |
|
| 2011 |
Shi M, Bradner J, Hancock AM, Chung KA, Quinn JF, Peskind ER, Galasko D, Jankovic J, Zabetian CP, Kim HM, Leverenz JB, Montine TJ, Ginghina C, Kang UJ, Cain KC, et al. Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression. Annals of Neurology. 69: 570-80. PMID 21400565 DOI: 10.1002/Ana.22311 |
0.377 |
|
| 2011 |
Ding Y, Won L, Britt JP, Lim SA, McGehee DS, Kang UJ. Enhanced striatal cholinergic neuronal activity mediates L-DOPA-induced dyskinesia in parkinsonian mice. Proceedings of the National Academy of Sciences of the United States of America. 108: 840-5. PMID 21187382 DOI: 10.1073/Pnas.1006511108 |
0.419 |
|
| 2010 |
Beeler JA, Cao ZF, Kheirbek MA, Ding Y, Koranda J, Murakami M, Kang UJ, Zhuang X. Dopamine-dependent motor learning: insight into levodopa's long-duration response. Annals of Neurology. 67: 639-47. PMID 20437561 DOI: 10.1002/Ana.21947 |
0.307 |
|
| 2010 |
Hong Z, Shi M, Chung KA, Quinn JF, Peskind ER, Galasko D, Jankovic J, Zabetian CP, Leverenz JB, Baird G, Montine TJ, Hancock AM, Hwang H, Pan C, Bradner J, ... Kang UJ, et al. DJ-1 and alpha-synuclein in human cerebrospinal fluid as biomarkers of Parkinson's disease. Brain : a Journal of Neurology. 133: 713-26. PMID 20157014 DOI: 10.1093/Brain/Awq008 |
0.316 |
|
| 2009 |
Rotstein M, Kang UJ. Consideration of gene therapy for paediatric neurotransmitter diseases. Journal of Inherited Metabolic Disease. 32: 387-94. PMID 19259783 DOI: 10.1007/S10545-009-1054-7 |
0.358 |
|
| 2008 |
Chen L, Ding Y, Cagniard B, Van Laar AD, Mortimer A, Chi W, Hastings TG, Kang UJ, Zhuang X. Unregulated cytosolic dopamine causes neurodegeneration associated with oxidative stress in mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 28: 425-33. PMID 18184785 DOI: 10.1523/Jneurosci.3602-07.2008 |
0.461 |
|
| 2008 |
Hong S, Kang UJ, Isacson O, Kim KS. Neural precursors derived from human embryonic stem cells maintain long-term proliferation without losing the potential to differentiate into all three neural lineages, including dopaminergic neurons. Journal of Neurochemistry. 104: 316-24. PMID 17944878 DOI: 10.1111/J.1471-4159.2007.04952.X |
0.304 |
|
| 2007 |
Potashkin JA, Kang UJ, Loomis PA, Jodelka FM, Ding Y, Meredith GE. MPTP administration in mice changes the ratio of splice isoforms of fosB and rgs9. Brain Research. 1182: 1-10. PMID 17936734 DOI: 10.1016/J.Brainres.2007.08.080 |
0.365 |
|
| 2007 |
Yang W, Chen L, Ding Y, Zhuang X, Kang UJ. Paraquat induces dopaminergic dysfunction and proteasome impairment in DJ-1-deficient mice. Human Molecular Genetics. 16: 2900-10. PMID 17823202 DOI: 10.1093/Hmg/Ddm249 |
0.348 |
|
| 2007 |
Ding Y, Restrepo J, Won L, Hwang DY, Kim KS, Kang UJ. Chronic 3,4-dihydroxyphenylalanine treatment induces dyskinesia in aphakia mice, a novel genetic model of Parkinson's disease. Neurobiology of Disease. 27: 11-23. PMID 17499513 DOI: 10.1016/J.Nbd.2007.03.013 |
0.418 |
|
| 2006 |
Meredith GE, Kang UJ. Behavioral models of Parkinson's disease in rodents: a new look at an old problem. Movement Disorders : Official Journal of the Movement Disorder Society. 21: 1595-606. PMID 16830310 DOI: 10.1002/Mds.21010 |
0.393 |
|
| 2006 |
Chung S, Shin BS, Hedlund E, Pruszak J, Ferree A, Kang UJ, Isacson O, Kim KS. Genetic selection of sox1GFP-expressing neural precursors removes residual tumorigenic pluripotent stem cells and attenuates tumor formation after transplantation. Journal of Neurochemistry. 97: 1467-80. PMID 16696855 DOI: 10.1111/J.1471-4159.2006.03841.X |
0.306 |
|
| 2006 |
Kim DW, Chung S, Hwang M, Ferree A, Tsai HC, Park JJ, Chung S, Nam TS, Kang UJ, Isacson O, Kim KS. Stromal cell-derived inducing activity, Nurr1, and signaling molecules synergistically induce dopaminergic neurons from mouse embryonic stem cells. Stem Cells (Dayton, Ohio). 24: 557-67. PMID 16123386 DOI: 10.1634/Stemcells.2005-0233 |
0.363 |
|
| 2005 |
Lin W, Kang UJ. Neuroprotective therapy in Parkinson's disease: current status and new directions from experimental and genetic clues. Journal of Clinical Neurology (Seoul, Korea). 1: 107-20. PMID 20396458 DOI: 10.3988/Jcn.2005.1.2.107 |
0.375 |
|
| 2005 |
Chen L, Cagniard B, Mathews T, Jones S, Koh HC, Ding Y, Carvey PM, Ling Z, Kang UJ, Zhuang X. Age-dependent motor deficits and dopaminergic dysfunction in DJ-1 null mice. The Journal of Biological Chemistry. 280: 21418-26. PMID 15799973 DOI: 10.1074/Jbc.M413955200 |
0.396 |
|
| 2005 |
Chung S, Hedlund E, Hwang M, Kim DW, Shin BS, Hwang DY, Kang UJ, Isacson O, Kim KS. The homeodomain transcription factor Pitx3 facilitates differentiation of mouse embryonic stem cells into AHD2-expressing dopaminergic neurons. Molecular and Cellular Neurosciences. 28: 241-52. PMID 15691706 DOI: 10.1016/J.Mcn.2004.09.008 |
0.369 |
|
| 2004 |
Kweon GR, Marks JD, Krencik R, Leung EH, Schumacker PT, Hyland K, Kang UJ. Distinct mechanisms of neurodegeneration induced by chronic complex I inhibition in dopaminergic and non-dopaminergic cells. The Journal of Biological Chemistry. 279: 51783-92. PMID 15469939 DOI: 10.1074/Jbc.M407336200 |
0.679 |
|
| 2004 |
Lee EA, Lee WY, Kim YS, Kang UJ. The effects of chronic L-DOPA therapy on pharmacodynamic parameters in a rat model of motor response fluctuations. Experimental Neurology. 184: 304-12. PMID 14637101 DOI: 10.1016/S0014-4886(03)00159-6 |
0.365 |
|
| 2003 |
Kang UJ, Nakamura K. Potential of gene therapy for pediatric neurotransmitter diseases: lessons from Parkinson's disease. Annals of Neurology. 54: S103-9. PMID 12891660 DOI: 10.1002/Ana.10654 |
0.312 |
|
| 2003 |
Hwang DY, Ardayfio P, Kang UJ, Semina EV, Kim KS. Selective loss of dopaminergic neurons in the substantia nigra of Pitx3-deficient aphakia mice. Brain Research. Molecular Brain Research. 114: 123-31. PMID 12829322 DOI: 10.1016/S0169-328X(03)00162-1 |
0.353 |
|
| 2002 |
Siderowf A, Stern M, Shoulson I, Kieburtz K, Oakes D, Day D, Shinaman A, Plumb S, Fahn S, Blindauer K, Lew M, Hurtig H, Lloyd M, Hauser R, Gauger L, ... ... Kang UJ, et al. A controlled trial of rasagiline in early Parkinson disease: The tempo study Archives of Neurology. 59: 1937-1943. PMID 12470183 DOI: 10.1001/Archneur.59.12.1937 |
0.355 |
|
| 2002 |
Chung S, Sonntag KC, Andersson T, Bjorklund LM, Park JJ, Kim DW, Kang UJ, Isacson O, Kim KS. Genetic engineering of mouse embryonic stem cells by Nurr1 enhances differentiation and maturation into dopaminergic neurons. The European Journal of Neuroscience. 16: 1829-38. PMID 12453046 DOI: 10.1046/J.1460-9568.2002.02255.X |
0.352 |
|
| 2002 |
Chang JW, Lee WY, Milstien S, Kang UJ. A site-specific mutation of tyrosine hydroxylase reduces feedback inhibition by dopamine in genetically modified cells grafted in parkinsonian rats. Journal of Neurochemistry. 83: 141-9. PMID 12358737 DOI: 10.1046/J.1471-4159.2002.01120.X |
0.373 |
|
| 2001 |
Nakamura K, Bindokas VP, Kowlessur D, Elas M, Milstien S, Marks JD, Halpern HJ, Kang UJ. Tetrahydrobiopterin Scavenges Superoxide in Dopaminergic Neurons Journal of Biological Chemistry. 276: 34402-34407. PMID 11447224 DOI: 10.1074/Jbc.M103766200 |
0.369 |
|
| 2000 |
Nakamura K, Ahmed M, Barr E, Leiden JM, Kang UJ. The localization and functional contribution of striatal aromatic L-amino acid decarboxylase to L-3,4-dihydroxyphenylalanine decarboxylation in rodent parkinsonian models. Cell Transplantation. 9: 567-76. PMID 11144954 DOI: 10.1177/096368970000900502 |
0.409 |
|
| 2000 |
Nakamura K, Won L, Heller A, Kang UJ. Preferential resistance of dopaminergic neurons to glutathione depletion in a reconstituted nigrostriatal system. Brain Research. 873: 203-11. PMID 10930545 DOI: 10.1016/S0006-8993(00)02425-2 |
0.373 |
|
| 2000 |
Nakamura K, Bindokas VP, Marks JD, Wright DA, Frim DM, Miller RJ, Kang UJ. The selective toxicity of 1-methyl-4-phenylpyridinium to dopaminergic neurons: the role of mitochondrial complex I and reactive oxygen species revisited. Molecular Pharmacology. 58: 271-8. PMID 10908294 DOI: 10.1124/Mol.58.2.271 |
0.372 |
|
| 2000 |
Nakamura K, Wright DA, Wiatr T, Kowlessur D, Milstien S, Lei XG, Kang UJ. Preferential resistance of dopaminergic neurons to the toxicity of glutathione depletion is independent of cellular glutathione peroxidase and is mediated by tetrahydrobiopterin. Journal of Neurochemistry. 74: 2305-14. PMID 10820190 DOI: 10.1046/J.1471-4159.2000.0742305.X |
0.364 |
|
| 1999 |
Frim DM, Kang UJ. Gene therapy for Parkinson's disease: review and update. Expert Opinion On Investigational Drugs. 8: 1551-1564. PMID 11139810 DOI: 10.1517/13543784.8.10.1551 |
0.362 |
|
| 1999 |
Chang JW, Wachtel SR, Young D, Kang UJ. Biochemical and anatomical characterization of forepaw adjusting steps in rat models of Parkinson's disease: studies on medial forebrain bundle and striatal lesions. Neuroscience. 88: 617-28. PMID 10197780 DOI: 10.1016/S0306-4522(98)00217-6 |
0.342 |
|
| 1999 |
Lee WY, Chang JW, Nemeth NL, Kang UJ. Vesicular Monoamine Transporter-2 and Aromaticl-Amino Acid Decarboxylase Enhance Dopamine Delivery afterl-3,4-Dihydroxyphenylalanine Administration in Parkinsonian Rats The Journal of Neuroscience. 19: 3266-3274. DOI: 10.1523/Jneurosci.19-08-03266.1999 |
0.416 |
|
| 1997 |
Wachtel SR, Bencsics C, Kang UJ. Role of aromatic L-amino acid decarboxylase for dopamine replacement by genetically modified fibroblasts in a rat model of Parkinson's disease. Journal of Neurochemistry. 69: 2055-63. PMID 9349551 DOI: 10.1046/J.1471-4159.1997.69052055.X |
0.341 |
|
| 1997 |
Nakamura K, Wang W, Kang UJ. The role of glutathione in dopaminergic neuronal survival. Journal of Neurochemistry. 69: 1850-8. PMID 9349527 DOI: 10.1046/J.1471-4159.1997.69051850.X |
0.382 |
|
| 1996 |
Bencsics C, Wachtel SR, Milstien S, Hatakeyama K, Becker JB, Kang UJ. Double transduction with GTP cyclohydrolase I and tyrosine hydroxylase is necessary for spontaneous synthesis of L-DOPA by primary fibroblasts. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 16: 4449-56. PMID 8699255 DOI: 10.1523/Jneurosci.16-14-04449.1996 |
0.387 |
|
| 1993 |
Kang U, Fisher L, Joh T, O'Malley K, Gage F. Regulation of dopamine production by genetically modified primary fibroblasts The Journal of Neuroscience. 13: 5203-5211. DOI: 10.1523/Jneurosci.13-12-05203.1993 |
0.395 |
|
| 1992 |
Gage FH, Kang UJ, Fisher LJ. Intracerebral grafting in the dopaminergic system: issues and controversy. Current Opinion in Neurobiology. 1: 414-9. PMID 1821685 DOI: 10.1016/0959-4388(91)90063-D |
0.365 |
|
| 1992 |
Kang UJ, Park DH, Wessel T, Baker H, Joh TH. DOPA-decarboxylation in the striata of rats with unilateral substantia nigra lesions Neuroscience Letters. 147: 53-57. PMID 1480324 DOI: 10.1016/0304-3940(92)90773-Z |
0.428 |
|
| 1991 |
Chen LS, Ray J, Fisher LJ, Kawaja MD, Schinstine M, Kang UJ, Gage FH. Cellular replacement therapy for neurologic disorders: potential of genetically engineered cells. Journal of Cellular Biochemistry. 45: 252-7. PMID 2066374 DOI: 10.1002/Jcb.240450305 |
0.33 |
|
| 1990 |
Park DH, Kang UJ, Moskowitz CB, Burke RE, Joh TH, Fahn S. Dopamine beta-hydroxylase activity in cerebrospinal fluid of idiopathic torsion dystonia. Neurology. 40: 1626-8. PMID 2215959 DOI: 10.1212/Wnl.40.10.1626 |
0.319 |
|
| 1989 |
Burke RE, Kang UJ, Jankovic J, Miller LG, Fahn S. Tardive akathisia: an analysis of clinical features and response to open therapeutic trials. Movement Disorders : Official Journal of the Movement Disorder Society. 4: 157-75. PMID 2567492 DOI: 10.1002/Mds.870040208 |
0.322 |
|
| 1989 |
Kang UJ, Fahn S, Schwarz H, Shoulson I, Vallejos H, Goldman J. Case 1, 1989: juvenile-onset parkinsonism, dystonia, and pyramidal tract signs. Movement Disorders : Official Journal of the Movement Disorder Society. 4: 363-70. PMID 2530440 DOI: 10.1002/Mds.870040414 |
0.316 |
|
| 1986 |
Friedman A, Kang UJ, Tatemichi TK, Burke RE. A case of parkinsonism following striatal lacunar infarction. Journal of Neurology, Neurosurgery, and Psychiatry. 49: 1087-8. PMID 3760901 DOI: 10.1136/Jnnp.49.9.1087 |
0.329 |
|
| Show low-probability matches. |